- Powerful Multinutrient Bone-Health System
- Builds-On Studied Bone-Up® Formula*
- 100% Ossein Microcrystalline Hydroxyapatite Complex
- Source of natural bone-growth factors
- Same As Original Bone-Up Plus:
- StimuCal™ and Natural MK-7
- Supports MidLifeEase®*
Ultra Bone-Up® provides StimuCal™ ossein MicroCrystalline HydroxyApatite (MCHA) (from free-range New Zealand calves), which includes the superior combination of the inorganic calcium lattice of MCHA within an organic protein milieu. StimuCal™ is rich in native type I collagen—the predominant protein found in bone—and has been clinically demonstrated not to disproportionately spike calcium blood levels as do other forms of calcium, such as the citrate and carbonate salt forms. StimuCal™ is combined with vitamin D3, vitamin K2 (as MK-7 from natural fermentation [a more bioavailable form of vitamin K]) and JarroSil® Activated Silicon® to support the deposition of calcium into the bones, as well as to assist in building up the organic bone matrix.* Also included are potassium citrate (systemic alkalizer) for optimal osteo support and Type II Collagen to support cartilage.* Bone Up® also supports cardiovascular and arterial health.*
HEALTH CLAIM: Adequate calcium and vitamin D as part of a healthful diet, along with physical activity, may reduce the risk of osteoporosis later in life.
Take 2 tablets 3 times per day (for a total of 6) with meals to facilitate maximum absorption, or as directed by your qualified healthcare professional.
NOTE: If you have a medical condition, are pregnant, lactating, trying to conceive, or taking medications (especially warfarin/Coumadin), consult your healthcare professional before using this product.
Cellulose, stearic acid (vegetable source), bovine collagen, magnesium stearate (vegetable source), methylsulfonylmethane (MSM), silicon dioxide and a food-grade coating.
Contains: Soy (in trace amounts).
No wheat, gluten, dairy, egg, fish/shellfish, or peanuts/tree nuts.
StimuCal™ is a registered trademark of PharmaZen Ltd., and is patent pending.